title: Differences in oral verapamil absorption as a function of time of day.
abstract: As part of a multiple dose bioavailability study, 80-mg verapamil hydrochloride tablets were administered to healthy subjects every 8 hours for 15 doses. Statistically significant successive decreases in verapamil maximum plasma concentrations (Cmax) and area under the concentration-time curve (AUC) values were observed corresponding to dosing at 8 AM, 4 PM, and 12 AM. Mean Cmax and AUC values from the 12 AM dose were decreased 36% and 30%, respectively, relative to those from the 8 AM dose. Similar effects on norverapamil pharmacokinetics were observed. Decreased Cmax and AUC values show that verapamil absorption is influenced by the time of day when doses are administered. Pharmacokinetic simulation results suggest that the rate of absorption is reduced approximately by one half and two thirds during the 4 PM and 12 AM dosing intervals, respectively, relative to the 8 AM dosing interval. The reductions in verapamil absorption as a function of time of administration observed in this study may in part explain previous reports of reduced antihypertensive effect during evening and night hours as compared to daytime hours.
authors.affiliation: Department of Pharmacokinetics, Warner-Lambert Company, Ann Arbor, Michigan.
authors.forename: M A
authors.initials: MA
authors.lastname: Eldon
authors.forename: M M
authors.initials: MM
authors.lastname: Battle
authors.forename: R E
authors.initials: RE
authors.lastname: Voigtman
authors.forename: W A
authors.initials: WA
authors.lastname: Colburn
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001682:Biological Availability; D006801:Humans; D007408:Intestinal Absorption; D008297:Male; D013997:Time Factors; D014700:Verapamil / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000097:blood / Q000493:pharmacokinetics*
chemical_list: C016904:norverapamil; D014700:Verapamil